PTK2 and cancer: Although the molecular mechanism(s) of FAK activation in response to chemotherapy stress are not known, stress-induced FAK activation supports cell survival (Shapiro et al., 2014), a cancer stem cell-like phenotype (Kolev et al., 2017), and chemotherapy resistance (Diaz Osterman et al., 2019) (Fig. 4).